Location: New York, NY
CIK: 0001263508 · Show all filings
Period: Q4 2018 (← Previous) (Next →)
Filing Date: Feb 13, 2019
Total Value: $12.21B (99.4% shares, 0.6% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Seattle Genetics, Inc. | 51,046,060 | $2.892B | 23.7% | $37.84 | — | COM | 812578102 |
| INCY | Incyte Corporation | 34,251,607 | $2.178B | 17.8% | $73.07 | -11.1% | COM | 45337C102 |
| ONC | BeiGene, Ltd. | 11,959,824 | $1.677B | 13.7% | $117.58 | — | SPONSORED ADR | 07725L102 |
| — | Alexion Pharmaceuticals, Inc. | 8,555,894 | $833M | 6.8% | $166.88 | — | COM | 015351109 |
| — | Genomic Health, Inc. | 11,744,010 | $756M | 6.2% | $31.71 | — | COM | 37244C101 |
| BMRN | BioMarin Pharmaceutical Inc. | 7,589,294 | $646M | 5.3% | $81.02 | +17.4% | COM | 09061G101 |
| ACAD | ACADIA Pharmaceuticals Inc. | 39,713,842 | $642M | 5.3% | $17.80 | +9.1% | COM | 004225108 |
| — | Amarin Corporation plc | 42,592,824 | $580M | 4.7% | $8.76 | — | SPONSORED ADR | 023111206 |
| ASND | Ascendis Pharma A/S | 2,837,352 | $178M | 1.5% | $29.89 | — | SPONSORED ADR | 04351P101 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 1,169,278 | $132M | 1.1% | $110.87 | +39.6% | COM | 558868105 |
| HRTX | Heron Therapeutics, Inc. | 5,018,104 | $130M | 1.1% | $17.34 | +58.6% | COM | 427746102 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 15,103,081 | $122M | 1.0% | $6.96 | +11.7% | COM | 09058V103 |
| — | Mirati Therapeutics, Inc. | 2,513,462 | $107M | 0.9% | $18.61 | — | COM | 60468T105 |
| ARGX | argenx SE | 1,019,557 | $97.95M | 0.8% | $59.75 | — | SPONSORED ADR | 04016X101 |
| — | Kiniksa Pharmaceuticals, Ltd. | 3,000,000 | $84.27M | 0.7% | $17.35 | — | COM CL A | G5269C101 |
| RYTM | Rhythm Pharmaceuticals, Inc. | 2,708,200 | $72.8M | 0.6% | $26.63 | +3.8% | COM | 76243J105 |
| — | Array BioPharma Inc. | 5,041,696 | $71.84M | 0.6% | $10.76 | — | COM | 04269X105 |
| KOD | Kodiak Sciences Inc. | 9,145,115 | $64.93M | 0.5% | $8.85 | 0.0% | COM | 50015M109 |
| — | Neurocrine Biosciences, Inc. | 53,270,000 | $63.43M | 0.5% | $1.24 | — | NOTE 2.25% 5/15/2024 | 64125CAD1 |
| CERS | Cerus Corporation | 10,749,937 | $54.5M | 0.4% | $4.67 | +24.2% | COM | 157085101 |
| — | Spark Therapeutics, Inc. | 1,384,130 | $54.17M | 0.4% | $76.99 | — | COM | 84652J103 |
| NBIX | Neurocrine Biosciences, Inc. | 730,355 | $52.16M | 0.4% | $44.09 | +117.3% | COM | 64125C109 |
| — | Principia Biopharma Inc. | 1,787,807 | $48.97M | 0.4% | $29.22 | — | COM | 74257L108 |
| — | Clementia Pharmaceuticals Inc. | 3,724,445 | $43.8M | 0.4% | $12.34 | — | COM | 185575107 |
| — | Invitae Corporation | 3,902,421 | $43.16M | 0.4% | $14.39 | — | COM | 46185L103 |
| — | GW Pharmaceuticals plc | 428,345 | $41.72M | 0.3% | $132.99 | — | ADS | 36197T103 |
| — | CymaBay Therapeutics, Inc. | 4,917,700 | $38.7M | 0.3% | $8.94 | — | COM | 23257D103 |
| — | Tricida, Inc. | 1,600,000 | $37.73M | 0.3% | $29.90 | — | COM | 89610F101 |
| — | DBV Technologies S.A. | 5,509,560 | $35.37M | 0.3% | $32.87 | — | SPONSORED ADR | 23306J101 |
| — | Zymeworks Inc. | 1,708,472 | $25.08M | 0.2% | $14.76 | — | COM | 98985W102 |
| INSM | Insmed Incorporated | 1,851,982 | $24.3M | 0.2% | $20.25 | -21.2% | COM PAR $.01 | 457669307 |
| — | Aquinox Pharmaceuticals, Inc. | 10,934,154 | $23.62M | 0.2% | $13.36 | — | COM | 03842B101 |
| — | Audentes Therapeutics, Inc. | 910,463 | $19.41M | 0.2% | $25.09 | — | COM | 05070R104 |
| QURE | uniQure N.V. | 605,000 | $17.44M | 0.1% | $18.33 | +51.8% | SHS | N90064101 |
| KRYS | Krystal Biotech, Inc. | 784,674 | $16.31M | 0.1% | $19.35 | +8.2% | COM | 501147102 |
| — | Merus N.V. | 1,160,014 | $16.24M | 0.1% | $8.27 | — | COM | N5749R100 |
| — | Aimmune Therapeutics, Inc. | 673,908 | $16.12M | 0.1% | $16.20 | — | COM | 00900T107 |
| XNCR | Xencor, Inc. | 440,186 | $15.92M | 0.1% | $11.07 | +231.6% | COM | 98401F105 |
| — | Solid Biosciences Inc. | 587,884 | $15.76M | 0.1% | $7.50 | — | COM | 83422E105 |
| — | MyoKardia, Inc. | 315,243 | $15.4M | 0.1% | $40.09 | — | COM | 62857M105 |
| — | Abeona Therapeutics Inc. | 2,103,164 | $15.02M | 0.1% | $7.28 | — | COM | 00289Y107 |
| — | Ra Pharmaceuticals, Inc. | 823,113 | $14.98M | 0.1% | $17.55 | — | COM | 74933V108 |
| — | BioMarin Pharmaceutical Inc. | 15,000,000 | $14.91M | 0.1% | $1.01 | — | NOTE 0.599% 8/1/2024 | 09061GAH4 |
| — | Idera Pharmaceuticals, Inc. | 4,836,237 | $13.4M | 0.1% | $1.32 | — | COM PAR | 45168K405 |
| — | Aeglea BioTherapeutics, Inc. | 1,713,604 | $12.84M | 0.1% | $5.64 | — | COM | 00773J103 |
| SGMO | Sangamo Therapeutics, Inc. | 999,823 | $11.48M | 0.1% | $11.28 | +10.1% | COM | 800677106 |
| — | ContraFect Corporation | 7,153,076 | $10.94M | 0.1% | $1.88 | — | COM | 212326102 |
| — | Novavax, Inc. | 4,718,318 | $8.682M | 0.1% | $1.88 | — | COM | 670002104 |
| — | Marker Therapeutics, Inc. | 1,500,000 | $8.325M | 0.1% | $5.55 | — | COM | 57055L107 |
| — | Bellicum Pharmaceuticals, Inc. | 2,677,818 | $7.819M | 0.1% | $22.31 | — | COM | 079481107 |
| ANAB | AnaptysBio, Inc. | 113,086 | $7.214M | 0.1% | $56.96 | +30.6% | COM | 032724106 |
| IFRX | InflaRx N.V. | 178,987 | $6.51M | 0.1% | $21.73 | +41.6% | COM | N44821101 |
| — | Spring Bank Pharmaceuticals, Inc. | 613,144 | $6.371M | 0.1% | $10.97 | — | COM | 849431101 |
| — | Albireo Pharma, Inc. | 250,000 | $6.133M | 0.1% | $22.99 | — | COM | 01345P106 |
| CPRX | Catalyst Pharmaceuticals, Inc. | 2,900,000 | $5.568M | 0.0% | $2.70 | +6.0% | COM | 14888U101 |
| AUTL | Autolus Therapeutics plc | 156,773 | $5.148M | 0.0% | $26.79 | — | SPON ADS | 05280R100 |
| HALO | Halozyme Therapeutics, Inc. | 299,969 | $4.389M | 0.0% | $7.32 | +117.9% | COM | 40637H109 |
| — | bluebird bio, Inc. | 40,000 | $3.968M | 0.0% | $41.25 | — | COM | 09609G100 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 131,250 | $3.936M | 0.0% | $29.69 | -5.2% | COM | 22663K107 |
| — | Forty Seven, Inc. | 250,000 | $3.93M | 0.0% | $16.00 | — | COM | 34983P104 |
| — | Acceleron Pharma Inc. | 83,900 | $3.654M | 0.0% | $37.72 | — | COM | 00434H108 |
| — | Assembly Biosciences, Inc. | 148,587 | $3.361M | 0.0% | $20.45 | — | COM | 045396108 |
| VKTX | Viking Therapeutics, Inc. | 425,000 | $3.251M | 0.0% | $11.90 | +0.5% | COM | 92686J106 |
| — | Syros Pharmaceuticals, Inc. | 574,835 | $3.202M | 0.0% | $16.82 | — | COM | 87184Q107 |
| — | Menlo Therapeutics Inc. | 700,000 | $2.884M | 0.0% | $37.58 | — | COM | 586858102 |
| — | Aevi Genomic Medicine, Inc. | 3,950,419 | $2.765M | 0.0% | $2.12 | — | COM | 00835P105 |
| — | Sierra Oncology, Inc. | 2,000,000 | $2.64M | 0.0% | $1.32 | — | COM | 82640U107 |
| APLS | Apellis Pharmaceuticals, Inc. | 196,078 | $2.586M | 0.0% | $22.98 | -33.2% | COM | 03753U106 |
| — | G1 Therapeutics, Inc. | 127,236 | $2.437M | 0.0% | $37.05 | — | COM | 3621LQ109 |
| GLPG | Galapagos NV | 25,072 | $2.3M | 0.0% | $51.50 | — | SPONSORED ADR | 36315X101 |
| — | ChemoCentryx, Inc. | 207,029 | $2.259M | 0.0% | $13.66 | — | COM | 16383L106 |
| — | Y-mAbs Therapeutics, Inc. | 102,800 | $2.091M | 0.0% | $26.56 | — | COM | 984241109 |
| ALKS | Alkermes plc | 67,000 | $1.977M | 0.0% | $70.02 | -47.3% | SHS | G01767105 |
| — | Orchard Therapeutics plc | 125,000 | $1.966M | 0.0% | $15.73 | — | ADS | 68570P101 |
| — | Foamix Pharmaceuticals Ltd. | 498,189 | $1.788M | 0.0% | $7.55 | — | SHS | M46135105 |
| NTLA | Intellia Therapeutics, Inc. | 128,538 | $1.755M | 0.0% | $26.35 | -29.5% | COM | 45826J105 |
| — | Achillion Pharmaceuticals, Inc. | 1,095,359 | $1.742M | 0.0% | $6.34 | — | COM | 00448Q201 |
| — | Adamas Pharmaceuticals, Inc. | 172,630 | $1.474M | 0.0% | $14.46 | — | COM | 00548A106 |
| — | Galmed Pharmaceuticals Ltd. | 215,594 | $1.473M | 0.0% | $11.90 | — | SHS | M47238106 |
| — | La Jolla Pharmaceutical Company | 154,675 | $1.459M | 0.0% | $29.30 | — | COM PAR $.0001 2 | 503459604 |
| — | Aravive, Inc. | 404,384 | $1.423M | 0.0% | $3.52 | — | COM | 03890D108 |
| RCUS | Arcus Biosciences, Inc. | 121,534 | $1.309M | 0.0% | $15.69 | -25.6% | COM | 03969F109 |
| — | Molecular Templates, Inc. | 254,230 | $1.027M | 0.0% | $5.84 | — | COM | 608550109 |
| — | Trillium Therapeutics Inc. | 505,262 | $864K | 0.0% | $12.19 | — | COM | 89620X506 |
| — | Dynavax Technologies Corporation | 75,000 | $686K | 0.0% | $24.55 | — | COM | 268158201 |
| INFIQ | Infinity Pharmaceuticals, Inc. | 580,400 | $685K | 0.0% | $1.54 | +17.1% | COM | 45665G303 |
| — | Proteon Therapeutics, Inc. | 298,591 | $678K | 0.0% | $9.69 | — | COM | 74371L109 |
| AQST | Aquestive Therapeutics, Inc. | 99,600 | $627K | 0.0% | $16.48 | -23.4% | COM | 03843E104 |
| — | Affimed N.V. | 200,000 | $622K | 0.0% | $6.30 | — | COM | N01045108 |
| — | Constellation Pharmaceuticals, Inc. | 133,333 | $535K | 0.0% | $6.73 | — | COM | 210373106 |
| FLGT | Fulgent Genetics, Inc. | 125,000 | $396K | 0.0% | $9.20 | -61.8% | COM | 359664109 |
| — | Sunesis Pharmaceuticals, Inc. | 556,665 | $231K | 0.0% | $4.37 | — | COM PAR | 867328700 |
| — | Ritter Pharmaceuticals, Inc. | 279,999 | $168K | 0.0% | $2.72 | — | COM | 767836307 |